How Safe and Fast Is Gabapentin for Orthostatic Tremor?
At a Glance
Gabapentin is sometimes used off-label for primary orthostatic tremor, but there is no standard dose or guaranteed time to benefit. Doctors start with a low dose, adjust for kidney function, and track standing ability and side effects before deciding whether to continue.
In this answer
5 sections
Gabapentin is one of the most common medications doctors try for primary orthostatic tremor, though it is not officially FDA-approved for this rare condition and is prescribed “off-label” [1]. The evidence supporting its use comes mainly from small studies and clinical experience, which show that while gabapentin can provide meaningful relief for some, the benefits are overall modest and inconsistent [2]. Because trying treatments for a rare disorder can be frustrating, a structured medication trial helps you and your doctor learn if this medication improves your quality of life without committing to it indefinitely.
How Dosing Works for Primary Orthostatic Tremor
Because gabapentin is used off-label for this condition, there is no single “standard” dose or guaranteed timeline for when it will start working [1]. Instead, your doctor will use a highly individualized approach:
- Start low and go slow: Doctors typically start with a low dose and increase it gradually over weeks to find the lowest dose that provides benefit with manageable side effects [2].
- Never adjust your own dose: You should only change your dose under your prescriber’s guidance. If you miss a dose, ask your doctor or pharmacist what to do—do not double up to catch up.
- Other options exist: If gabapentin is ineffective or poorly tolerated, other medications (like clonazepam) may be considered [3].
The Crucial Role of Kidney Function
Gabapentin is processed entirely by your kidneys, meaning it is eliminated from your body unchanged in your urine [4]. The most important factor in determining your safe starting and target doses is an estimate of your kidney function, calculated using laboratory tests like eGFR (estimated glomerular filtration rate) or creatinine clearance [5].
- Reduced clearance means higher risks: If your kidney function is reduced—whether due to age, kidney disease, or temporary dehydration—gabapentin stays in your system longer [4][6].
- Dose adjustments are required: Taking a standard dose with reduced kidney function can lead to accidentally high levels of the drug in your body, significantly increasing the risk of severe sleepiness, confusion, and falls [7][8].
- Ongoing monitoring: Your doctor must select the right calculation for you and may need to recalculate your kidney function after an acute illness, dehydration, or a change in your health status. If you are on dialysis, special dosing schedules are required [9].
Monitoring for Benefit
Because the benefits can be modest, clearly track whether the medication is actually helping you [2].
- Establish a baseline: Document your baseline standing balance, mobility, and fall frequency before starting. Because gabapentin itself can cause dizziness, knowing your baseline helps determine if new unsteadiness is from the tremor or the medication [10][11].
- Track your standing tolerance: Keep a daily log of how long you can comfortably stand and whether your fear of falling improves.
- Use structured scales: Your doctor might use tools like the Orthostatic Tremor Severity and Disability Scale to objectively measure changes in your symptoms [12].
Safety and Side Effects
Gabapentin carries risks, particularly for your nervous system, and these risks increase at higher doses or if your kidney function declines [13]. To reduce fall risk early on, rise carefully from sitting or lying down, and avoid driving or operating machinery until you know how the drug affects you.
Common Side Effects to Monitor
- Dizziness, sleepiness, and imbalance: These are the most common side effects [11]. Because primary orthostatic tremor already affects your stability, adding a medication that causes dizziness or ataxia (poor muscle control) requires careful monitoring to prevent falls [14][13].
- Cognitive effects: Especially in older adults or those with impaired kidneys, gabapentin can cause confusion, memory issues, or altered mental status [15][8]. Contact your prescriber if you experience persistent confusion.
- Gradual leg swelling (Peripheral Edema): Gabapentin can cause fluid buildup, typically in both legs or feet, weeks after starting [16]. If you notice new, gradual swelling in both legs, contact your doctor for a possible dose reduction [11]. (Note: Sudden, painful swelling in one leg, or swelling accompanied by chest pain or shortness of breath, is a medical emergency and not a typical gabapentin side effect.)
When to Seek Emergency Help
Seek immediate emergency medical care (do not wait to call your prescriber) if you experience:
- Severe Allergic Reactions: Swelling of the face, lips, tongue, or throat, hives, or sudden trouble breathing.
- Dangerous Breathing Changes: Gabapentin can cause respiratory depression (dangerously slow or shallow breathing, blue lips, or unusual difficulty waking up) [17]. This risk is much higher if you also take opioids, benzodiazepines, sleep aids, sedating antihistamines, alcohol, or other central nervous system depressants (substances that slow down brain activity) [18][19]. Avoid alcohol and other sedatives unless cleared by your doctor.
- Mood Changes: New or worsening depression, severe mood changes, or suicidal thoughts.
Tapering: Do Not Stop Without a Plan
Unless you are experiencing an emergency like a severe allergic reaction or dangerous breathing changes, do not stop taking gabapentin on your own [20]. Abruptly stopping gabapentin, particularly after taking regular or higher doses for a long time, can cause withdrawal symptoms such as anxiety, insomnia, nausea, sweating, and altered mental status [20][21]. Stopping abruptly is also especially dangerous if you have a history of seizures.
If the medication is ineffective or side effects are intolerable, your doctor will create an individualized plan to slowly taper (gradually reduce) your dose [22]. The pace of the taper depends on your current dose, how long you have been taking it, and your symptoms. Tapering can take weeks or months, and your doctor will adjust the speed if withdrawal symptoms occur [22].
Common questions in this guide
How quickly might gabapentin help primary orthostatic tremor?
What dose of gabapentin is usually used for orthostatic tremor?
Why does kidney function affect gabapentin dosing?
What gabapentin side effects require urgent medical help?
Can I stop gabapentin suddenly if it does not help?
What should I avoid while starting gabapentin?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on Primary orthostatic tremor.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since gabapentin is off-label, what realistic benefits should I expect for my primary orthostatic tremor, and how long is our trial period?
- 2.What is my current kidney function (eGFR or creatinine clearance), and how did that determine the starting dose you prescribed?
- 3.What schedule should we use to slowly increase the dose, and what should I do if I accidentally miss a dose?
- 4.If gabapentin doesn't work for me, what other treatment options might we consider, and what is your plan for safely tapering me off?
- 5.Am I taking any other medications, such as opioids, sleep aids, or allergy medicines, that could dangerously interact with gabapentin?
References
References (22)
- 1
Systematic review of pharmacological treatment options for orthostatic tremor in prospective patient cohorts and randomized controlled trials.
Sauthoff L, Achutegui MI, Ye L, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(8)):3419-3425 doi:10.1007/s10072-025-08129-3.
PMID: 40155580 - 2
Orthostatic Tremor: Pathophysiology Guiding Treatment.
Whitney D, Bhatti D, Torres-Russotto D
Current treatment options in neurology 2018; (20(9)):35 doi:10.1007/s11940-018-0524-3.
PMID: 30032366 - 3
Orthostatic tremor and its subtypes: a single centre cohort of 74 patients.
Jesuthasan A, Bandrivska S, Colmenares LA, et al.
Journal of neurology 2026; (273(2)):100.
PMID: 41591552 - 4
More Drug Monitoring and Less CT Scans of the Brain: Gabapentin Overdose in Two Peritoneal Dialysis Patients.
Lehmann K, Diab S, Meyer TM, et al.
Case reports in nephrology and dialysis 2022; (12(3)):145-149 doi:10.1159/000525922.
PMID: 36518357 - 5
Population pharmacokinetics of gabapentin in healthy Korean subjects with influence of genetic polymorphisms of ABCB1.
Tran P, Yoo HD, Ngo L, et al.
Journal of pharmacokinetics and pharmacodynamics 2017; (44(6)):567-579 doi:10.1007/s10928-017-9549-6.
PMID: 29018999 - 6
Pharmacokinetics and Saturable Absorption of Gabapentin in Nursing Home Elderly Patients.
Ahmed GF, Bathena SP, Brundage RC, et al.
The AAPS journal 2017; (19(2)):551-556 doi:10.1208/s12248-016-0022-z.
PMID: 28070716 - 7
Evaluation of Gabapentin and Pregabalin Use in Hospitalized Patients With Decreased Kidney Function.
Knowles GM, LaFleur GE, Churchwell MD
The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians 2024; (40(1)):30-36 doi:10.1177/87551225231217906.
PMID: 38318261 - 8
Higher-Dose Gabapentinoids and the Risk of Adverse Events in Older Adults With CKD: A Population-Based Cohort Study.
Muanda FT, Weir MA, Ahmadi F, et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2022; (80(1)):98-107.e1 doi:10.1053/j.ajkd.2021.11.007.
PMID: 34979160 - 9
Extracorporeal Treatment for Gabapentin and Pregabalin Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup.
Bouchard J, Yates C, Calello DP, et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2022; (79(1)):88-104 doi:10.1053/j.ajkd.2021.06.027.
PMID: 34799138 - 10
Lessons I have learned from my patients: everyday life with primary orthostatic tremor.
Vidailhet M, Roze E, Maugest L, Gallea C
Journal of clinical movement disorders 2017; (4()):1 doi:10.1186/s40734-016-0048-5.
PMID: 28101372 - 11
Gabapentin for chronic neuropathic pain in adults.
Wiffen PJ, Derry S, Bell RF, et al.
The Cochrane database of systematic reviews 2017; (6()):CD007938 doi:10.1002/14651858.CD007938.pub4.
PMID: 28597471 - 12
Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT-10).
Merola A, Torres-Russotto DR, Stebbins GT, et al.
Movement disorders : official journal of the Movement Disorder Society 2020; (35(10)):1796-1801 doi:10.1002/mds.28142.
PMID: 32562441 - 13
Safety of Gabapentin Prescribed for Any Indication in a Large Clinical Cohort of 571,718 US Veterans with and without Alcohol Use Disorder.
Rentsch CT, Morford KL, Fiellin DA, et al.
Alcoholism, clinical and experimental research 2020; (44(9)):1807-1815 doi:10.1111/acer.14408.
PMID: 32628784 - 14
Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use.
Calandre EP, Rico-Villademoros F, Slim M
Expert review of neurotherapeutics 2016; (16(11)):1263-1277 doi:10.1080/14737175.2016.1202764.
PMID: 27345098 - 15
Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based study.
Fleet JL, Dixon SN, Kuwornu PJ, et al.
PloS one 2018; (13(3)):e0193134 doi:10.1371/journal.pone.0193134.
PMID: 29538407 - 16
Gabapentinoid-induced peripheral edema and acute heart failure: A translational study combining pharmacovigilance data and in vitro animal experiments.
Largeau B, Bordy R, Pasqualin C, et al.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2022; (149()):112807 doi:10.1016/j.biopha.2022.112807.
PMID: 35303569 - 17
Gabapentinoids in Chronic Kidney Disease: A Closer Look at Respiratory Risk.
Harven L, Alexander Paxton R, Giuliano C
The Annals of pharmacotherapy 2026; (60(8)):779-785 doi:10.1177/10600280251401899.
PMID: 41450155 - 18
Risk of major adverse events associated with gabapentinoid and opioid combination therapy: A systematic review and meta-analysis.
Hahn J, Jo Y, Yoo SH, et al.
Frontiers in pharmacology 2022; (13()):1009950 doi:10.3389/fphar.2022.1009950.
PMID: 36304170 - 19
Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: A nested case-control study.
Olopoenia A, Camelo-Castillo W, Qato DM, et al.
Lancet regional health. Americas 2022; (13()):100302 doi:10.1016/j.lana.2022.100302.
PMID: 36777316 - 20
Gabapentin: Abuse, Dependence, and Withdrawal.
Mersfelder TL, Nichols WH
The Annals of pharmacotherapy 2016; (50(3)):229-33 doi:10.1177/1060028015620800.
PMID: 26721643 - 21
Complex encephalopathy arising from the combination of opioids and gabapentin.
Singh H, Handa R, Kak V, Wasilewski A
BMJ case reports 2019; (12(4)) doi:10.1136/bcr-2018-228354.
PMID: 31005866 - 22
Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case report.
Deng H, Benhamou OM, Lembke A
Journal of addictive diseases 2021; (39(4)):575-578 doi:10.1080/10550887.2021.1907502.
PMID: 33783336
This page is for informational purposes only and does not constitute medical advice. Your prescriber should individualize gabapentin dosing, kidney-function monitoring, interaction checks, and tapering for your situation.